These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 1097148

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G, Roser P, Nadulski T, Stadelmann AM, Gallinat J.
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
    Hempel BJ, Clasen MM, Nelson KH, Woloshchuk CJ, Riley AL.
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):205-213. PubMed ID: 29648861
    [Abstract] [Full Text] [Related]

  • 32. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
    Klein C, Karanges E, Spiro A, Wong A, Spencer J, Huynh T, Gunasekaran N, Karl T, Long LE, Huang XF, Liu K, Arnold JC, McGregor IS.
    Psychopharmacology (Berl); 2011 Nov; 218(2):443-57. PubMed ID: 21667074
    [Abstract] [Full Text] [Related]

  • 33. Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.
    Jacobs DS, Kohut SJ, Jiang S, Nikas SP, Makriyannis A, Bergman J.
    Exp Clin Psychopharmacol; 2016 Oct; 24(5):320-330. PubMed ID: 27690502
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T.
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [Abstract] [Full Text] [Related]

  • 37. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
    El-Alfy AT, Ivey K, Robinson K, Ahmed S, Radwan M, Slade D, Khan I, ElSohly M, Ross S.
    Pharmacol Biochem Behav; 2010 Jun; 95(4):434-42. PubMed ID: 20332000
    [Abstract] [Full Text] [Related]

  • 38. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW, Karniol IG.
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. II. In vitro investigation using cultured mouse splenocytes.
    Baczynsky WO, Zimmerman AM.
    Pharmacology; 1983 Jul; 26(1):12-9. PubMed ID: 6298842
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.